• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

View Calendar

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • John Russo, USA

    John Russo, USA
    final3878

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Art Eggert, USA

    Art Eggert, USA

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Philip Brindle, England

    Philip Brindle, England

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • David Bishop, UK

    David Bishop, UK

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Lombana, Spain

    Lombana, Spain

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • John Sweeney, USA

    John Sweeney, USA

  • Chih Ching Darren Wong, Malaysia

    Chih Ching Darren Wong, Malaysia

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • Marcelo Farinelli, Brazil

    Marcelo Farinelli, Brazil

  • Eddy Lefrancois, Canada

    Eddy Lefrancois, Canada

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Steve

    Steve

  • Phil Rossall, UK

    Phil Rossall, UK

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Yolanda Armendariz, Mexico

    Yolanda Armendariz, Mexico

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login